Arcadia Biosciences Inc reports results for the quarter ended in June - Earnings Summary

Arcadia Biosciences

10/08/2023 22:02

* Arcadia Biosciences Inc  RKDA.OQ  reported a quarterly
adjusted
loss of $2.65​​ per share for the quarter ended in June. The
mean expectation of two analysts for the quarter was for a loss
of $4.80 per share.
    * Revenue fell 64% to $1.39 million from a year ago;
analysts
expected $1.82 million. 
    * Arcadia Biosciences Inc's reported EPS for the quarter was
61
cents​.
    * The mean earnings estimate of analysts had fallen by
about 0.6%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Arcadia Biosciences Inc shares had risen by 13.4% this
quarter and lost 59.4% so far this year.
    * The company reported quarterly net income of $823
thousand.
    * Wall Street's median 12-month price target for Arcadia
Biosciences Inc is $17.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 10 at 09:02 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -4.80          -2.65          Beat
 Mar. 31 2023      -6.85          -10.86         Missed
 Dec. 31 2022      -6.80          -6.29          Beat
 Sep. 30 2022      -8.40          -4.80          Beat